Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Psoriasis After Apremilast Failure
NCT02749370Phase 4Completed
- Sponsor
- Amgen
- Start
- May 2016
- Primary completion
- Aug 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept in plaque psoriasis, sponsored by Amgen. Started May 2016; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02749370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02749370.